Malignant disease gastrointestinal

Sorafenib is a protein kinase inhibitor that is used in malignant disease. Patients should be advised to take tablets an hour before food or on an empty stomach. Side-effects include gastrointestinal disturbances including diarrhoea or constipation, dyspepsia, dysphagia and anorexia. 

Malignant diseases Psychiatric diseases Serious disorders of the eye and ear Serious gastrointestinal diseases... 

Gastrointestinal Gastrointestinal perforation, in some cases fatal, has been observed in patients receiving rituximab for malignant disease in most of these cases, rituximab was administered with chemotherapy [295 298 ]. 

Serum cancer antigen 125 (CA-125) is the most extensively evaluated tumor marker for ovarian cancer. Unfortunately, the CA-125 determination is non-specific, and elevated levels can be associated with a number of other gynecologic and gastrointestinal diseases. CA-125 levels in a woman without ovarian cancer, though, are static or tend to decrease over time, whereas levels associated with malignancy will continue to rise.10 Since CA-125 is a non-specific marker, there is no standard recommendation for routine screening for prevention of ovarian cancer. 

Oral anticoagulants are ordinarily contraindicated in the presence of active or past gastrointestinal ulceration thrombocytopenia hepatic or renal disease malignant hypertension recent brain, eye, or spinal cord surgery bacterial endocarditis chronic alcoholism and pregnancy. These agents also should not be prescribed for individuals with physically hazardous occupations. 

Osteolytic tumors may induce bone destruction either through local invasion, or by a secondary metastatic bone disease. The most frequent types of primary tumors that develop into metastatic bone disease are, in the order of prevalence breast, prostate, thyroid, kidney, and bronchial tumors, whereas esophageal, gastrointestinal and rectal tumors are much less metastatic [11]. Very often, the destruction of bone in a metastatic bone disease leads to hypercalcemia of malignancy, which also responds to BPs. In addition, hematological cancers such as... 

Monocytosis (>800/mm of blood) occurs with some infections (e.g., tuberculosis, histoplasmosis, toxoplasmosis, bacterial endocarditis, and salmonellosis), collagen vascular diseases (rheumatoid arthritis and systematic lupus erythematosus), gastrointestinal disorders (ulcerative cohtis and alcoholic liver disease), leukemias, and up to 60% of nonhematologic malignancies, whereas abnormally low monocyte concentrations occur in patients with hairy cell leukemia or aplastic anemia." ... 

---